Drug Shortage Report for TEVA-ATOMOXETINE

Last updated on 2021-04-15 History
Report ID 110670
Drug Identification Number 02314568
Brand name TEVA-ATOMOXETINE
Common or Proper name ATOMOXETINE 18MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ATOMOXETINE
Strength(s) 18MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 30
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-01
Estimated end date
Actual end date 2021-04-09
Shortage status Resolved
Updated date 2021-04-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-04-15 French Compare
v11 2021-04-15 English Compare
v10 2020-08-20 French Compare
v9 2020-08-20 English Compare
v8 2020-08-13 French Compare
v7 2020-08-13 English Compare
v6 2020-07-30 French Compare
v5 2020-07-30 English Compare
v4 2020-07-09 French Compare
v3 2020-07-09 English Compare
v2 2020-04-02 French Compare
v1 2020-04-02 English Compare

Showing 1 to 12 of 12